AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON”…
Matinas BioPharma Receives Notice of Non-Compliance withNYSE AmericanContinued Listing Standards
BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc.…
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
– Released positive topline data from Phase 1 study of IV rademikibart…
Emerald Clinical Trials Honored with 2026 Asia Pacific Biopharma Excellence Award for Outstanding Patient Recruitment & Engagement
SINGAPORE, March 12, 2026 /PRNewswire/ -- Emerald Clinical Trials, a leading global…
Crescent Biopharma Announces Grants of Inducement Awards
March 06, 2026 16:15 ET | Source: Crescent Biopharma, Inc. WALTHAM, Mass.,…
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026 16:15 ET | Source: Zenas BioPharma WALTHAM, Mass., Jan.…
Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response
• Patient 1 of Cohort 1 has now completed the 24-month follow-up…
Global Biopharma Solutions Leader Selects Kneat to Drive Digital Validation Excellence
LIMERICK, Ireland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI)…
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
IRVINE, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON”…
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 19, 2025 16:15 ET | Source: Zenas BioPharma WALTHAM, Mass., Dec.…
